Get the Stockscreener App
1.50
0.66%
-0.01
Repare Therapeutics Inc stock is traded at $1.50, with a volume of 109.39K.
It is down -0.66% in the last 24 hours and up +5.63% over the past month.
Repare Therapeutics Inc is a precision medicine oncology company focused on the development of synthetic lethality-based therapies for patients with cancer. The Company's focus is the research, development and commercialization of precision oncology drugs targeting specific vulnerabilities of tumors in genetically defined patient populations.
See More
Previous Close:
$1.51
Open:
$1.5
24h Volume:
109.39K
Relative Volume:
0.36
Market Cap:
$64.34M
Revenue:
$51.13M
Net Income/Loss:
$-93.80M
P/E Ratio:
-0.6726
EPS:
-2.23
Net Cash Flow:
$-129.10M
1W Performance:
-3.85%
1M Performance:
+5.63%
6M Performance:
+22.95%
1Y Performance:
-56.01%
1-Day Range:
$1.485
$1.52
1-Week Range:
$1.485
$1.62
52-Week Range:
$0.89
$4.0695
Repare Therapeutics Inc Stock (RPTX) Company Profile
Name
Repare Therapeutics Inc
Sector
Industry
Phone
(857) 412-7018
Address
7171 FREDERICK BANTING, SAINT-LAURENT, QC
Compare RPTX with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
RPTX
Repare Therapeutics Inc
|
1.50 | 64.77M | 51.13M | -93.80M | -129.10M | -2.23 |
|
VRTX
Vertex Pharmaceuticals Inc
|
462.13 | 117.32B | 11.10B | -988.90M | -1.26B | -3.92 |
|
REGN
Regeneron Pharmaceuticals Inc
|
558.87 | 58.89B | 14.09B | 4.50B | 2.96B | 39.28 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
401.80 | 51.14B | 2.35B | -269.70M | -75.39M | -2.09 |
|
ARGX
Argen X Se Adr
|
673.80 | 41.02B | 2.58B | 1.06B | -1.28B | 16.33 |
|
ONC
Beone Medicines Ltd Adr
|
299.01 | 32.59B | 3.81B | -644.79M | -669.77M | -6.24 |
Repare Therapeutics Inc Stock (RPTX) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Jun-09-23 | Upgrade | Stifel | Hold → Buy |
| Feb-03-23 | Downgrade | Morgan Stanley | Overweight → Equal-Weight |
| Jan-06-23 | Initiated | CapitalOne | Overweight |
| Apr-12-22 | Downgrade | Stifel | Buy → Hold |
| Mar-17-22 | Resumed | Goldman | Buy |
| Sep-23-21 | Initiated | Stifel | Buy |
| Sep-13-21 | Initiated | H.C. Wainwright | Buy |
| Jun-28-21 | Initiated | Guggenheim | Buy |
| Mar-01-21 | Initiated | Berenberg | Buy |
| Oct-28-20 | Initiated | Northland Capital | Outperform |
| Jul-14-20 | Initiated | Cowen | Outperform |
| Jul-14-20 | Initiated | Goldman | Neutral |
| Jul-14-20 | Initiated | Morgan Stanley | Overweight |
| Jul-14-20 | Initiated | Piper Sandler | Overweight |
View All
Repare Therapeutics Inc Stock (RPTX) Latest News
Quantitative breakdown of Repare Therapeutics Inc. recent moveFree AI Forecast for Trending Stocks - Newser
Head to Head Comparison: Repare Therapeutics (NASDAQ:RPTX) and Provectus Biopharmaceuticals (OTCMKTS:PVCT) - Defense World
Will Repare Therapeutics Inc. benefit from macro trendsLong-Term Investment Strategy Summary Guide - Newser
Repare Therapeutics (RPTX) Projected to Post Quarterly Earnings on Tuesday - MarketBeat
Is Repare Therapeutics Inc. a growth stock or a value stockEntry Signal Signals To Watch Now - jammulinksnews.com
What makes Repare Therapeutics Inc. stock price move sharplyFinancial News Report That Work - jammulinksnews.com
Best data tools to analyze Repare Therapeutics Inc. stockCapital Growth Plan for New Investors - Newser
Can Repare Therapeutics Inc. hit a new high this monthAI Powered Stock Trend Prediction Model - Newser
What is the risk reward ratio of investing in Repare Therapeutics Inc. stockStock Strategy Picks For 2025 - jammulinksnews.com
ARK Investment Management LLC Sells 875,514 Shares of Repare Therapeutics Inc. (NASDAQ:RPTX) - MarketBeat
How high can Repare Therapeutics Inc. stock goTrading Watchlist with Real Time Filters - Newser
Pattern recognition hints at Repare Therapeutics Inc. upsidePortfolio Safety Metrics and Return Analysis - Newser
Analyzing recovery setups for Repare Therapeutics Inc. investorsLong Term Equity Screener with Safety Metrics - Newser
Repare Therapeutics Inc.’s Price Action Aligns with Quant SignalsLow Risk Picks for Daily Trading Released - metal.it
Repare Therapeutics (NASDAQ:RPTX) Shares Up 0.6%Should You Buy? - MarketBeat
Is Repare Therapeutics Inc. Stock a Good Fit for Conservative InvestorsEquity Forecast with Predictive AI Screener - Newser
Real Time Chart Alerts Flash Bullish on Repare Therapeutics Inc.AI Driven Stock Trend Forecast Shows Momentum Shift - metal.it
Why Repare Therapeutics Inc. stock attracts strong analyst attentionFree Risk Adjusted Technical Entry Plan - Newser
Ichimoku Cloud Indicates Uncertainty Around Repare Therapeutics Inc.Market Surge Signal for Swing Traders Triggered - metal.it
When is Repare Therapeutics Inc. stock expected to show significant growthBuild wealth with high-performing stocks - jammulinksnews.com
How many analysts rate Repare Therapeutics Inc. as a “Buy”Market-beating returns - jammulinksnews.com
How high can Repare Therapeutics Inc. stock go Strong Buy Signal Summary with Entry Zone - Newser
What are the technical indicators suggesting about Repare Therapeutics Inc.Breakneck growth rates - jammulinksnews.com
How does Repare Therapeutics Inc. compare to its industry peersBuild wealth with high-performing stocks - jammulinksnews.com
What are Repare Therapeutics Inc. company’s key revenue driversTremendous gains - jammulinksnews.com
How strong is Repare Therapeutics Inc. company’s balance sheetDiscover dynamic stocks ready to soar - jammulinksnews.com
How Repare Therapeutics Inc. stock performs during market volatilityLow Risk Trading Ideas - Newser
Repare Therapeutics (NASDAQ:RPTX) Trading 0.6% Higher – What’s Next? - Defense World
Repare Therapeutics Inc Stock (RPTX) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.93%
0.15%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):